Corrigendum to "Design of selective PI3Kδ inhibitors using an iterative scaffold-hopping workflow" [Bioorg. Med. Chem. Lett. 29 (2019) 2575-2580]
Bioorg Med Chem Lett
.
2020 Aug 15;30(16):127363.
doi: 10.1016/j.bmcl.2020.127363.
Epub 2020 Jun 23.
Authors
Xavier Fradera
1
,
Joey L Methot
2
,
Abdelghani Achab
2
,
Matthew Christopher
2
,
Michael D Altman
3
,
Hua Zhou
2
,
Meredeth A McGowan
2
,
Sam D Kattar
2
,
Kevin Wilson
2
,
Yudith Garcia
2
,
Martin A Augustin
4
,
Charles A Lesburg
3
,
Sanjiv Shah
5
,
Peter Goldenblatt
5
,
Jason D Katz
2
Affiliations
1
Computational and Structural Chemistry, Merck & Co., Inc., Boston, MA, USA. Electronic address:
[email protected]
.
2
Discovery Chemistry, Merck & Co., Inc., Boston, MA, USA.
3
Computational and Structural Chemistry, Merck & Co., Inc., Boston, MA, USA.
4
Proteros Biostructures GmbH, Martinsried, Germany.
5
In vitro Pharmacology, Merck & Co., Inc., Boston, MA, USA.
PMID:
32591133
DOI:
10.1016/j.bmcl.2020.127363
No abstract available
Publication types
Published Erratum